DelphX Announces Grant of Stock Options
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), a leader in developing new structured products for the fixed income market, has announced the grant of 1,200,000 stock options to eligible participants. The options, approved by the company's Board of Directors, have a two-year maturity and can be exercised at $0.25 per common share. This grant is part of DelphX's stock option plan and aims to align the interests of participants with those of shareholders, potentially incentivizing performance and retention.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), un leader nello sviluppo di nuovi prodotti strutturati per il mercato obbligazionario, ha annunciato il conferimento di 1.200.000 opzioni su azioni ai partecipanti idonei. Le opzioni, approvate dal Consiglio di Amministrazione dell'azienda, hanno una scadenza di due anni e possono essere esercitate a $0,25 per azione comune. Questo conferimento fa parte del piano di opzioni su azioni di DelphX e ha l'obiettivo di allineare gli interessi dei partecipanti a quelli degli azionisti, incentivando potenzialmente le prestazioni e la retention.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), un líder en el desarrollo de nuevos productos estructurados para el mercado de renta fija, ha anunciado la concesión de 1.200.000 opciones sobre acciones a participantes elegibles. Las opciones, aprobadas por la Junta Directiva de la compañía, tienen un vencimiento de dos años y pueden ejercerse a $0,25 por acción común. Esta concesión es parte del plan de opciones sobre acciones de DelphX y tiene como objetivo alinear los intereses de los participantes con los de los accionistas, potencialmente incentivando el rendimiento y la retención.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF)는 고정 수익 시장을 위한 새로운 구조화 상품 개발의 선두주자로서, 적격 참가자에게 1,200,000주 옵션을 부여한다고 발표했습니다. 이 옵션은 회사의 이사회에서 승인되었으며, 2년의 만기를 가지고 있고 주당 $0.25에 행사할 수 있습니다. 이 부여는 DelphX의 주식 옵션 계획의 일환이며, 참여자의 이익을 주주와 일치시키고 성과 및 유지 보상을 장려하는 것을 목표로 합니다.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), un leader dans le développement de nouveaux produits structurés pour le marché de la dette, a annoncé l'octroi de 1.200.000 options d'achat d'actions aux participants éligibles. Les options, approuvées par le conseil d'administration de l'entreprise, ont une délai de deux ans et peuvent être exercées à 0,25 $ par action ordinaire. Cet octroi fait partie du plan d'options d'achat d'actions de DelphX et vise à aligner les intérêts des participants avec ceux des actionnaires, incitant potentiellement à la performance et à la rétention.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), ein führendes Unternehmen in der Entwicklung neuer strukturierter Produkte für den Rentenmarkt, hat die Gewährung von 1.200.000 Aktienoptionen an berechtigte Teilnehmer bekannt gegeben. Die Optionen, die vom Vorstand des Unternehmens genehmigt wurden, haben eine zwei-jährige Laufzeit und können zu 0,25 $ pro Stammaktie ausgeübt werden. Diese Gewährung ist Teil des Aktienoptionsplans von DelphX und zielt darauf ab, die Interessen der Teilnehmer mit denen der Aktionäre in Einklang zu bringen, um möglicherweise Leistungen und Bindung zu incentivieren.
- Grant of 1,200,000 stock options to eligible participants
- Options exercisable at $0.25 per common share
- None.
Toronto, Ontario--(Newsfile Corp. - August 27, 2024) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products for the fixed income market, announces that its Board of Directors has approved the grant of 1,200,000 stock options (the "Options") to eligible participants under its stock option plan (the "Plan"). The Options have a two-year maturity and are exercisable for common shares of DelphX at an exercise price of
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables fixed income dealers to offer new private placement securities that provide mitigation of spread and capital charge losses when downgrades occur, while allowing for attractive returns. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
- Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds;
- Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade exposure of an underlying security in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by BNY Mellon. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/221301
FAQ
How many stock options did DelphX Capital Markets (DPXCF) grant on August 27, 2024?
What is the exercise price of the stock options granted by DelphX (DPXCF)?
What is the maturity period of the stock options granted by DelphX Capital Markets (DPXCF)?
On which stock exchanges is DelphX Capital Markets traded?
